Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
42.51
-0.13 (-0.30%)
Aug 14, 2025, 1:53 PM - Market open
Supernus Pharmaceuticals Market Cap
Supernus Pharmaceuticals has a market cap or net worth of $2.38 billion as of August 14, 2025. Its market cap has increased by 41.00% in one year.
Market Cap
2.38B
Enterprise Value
1.89B
1-Year Change
41.00%
Ranking
Category
Stock Price
$42.51
Market Cap Chart
Since May 1, 2012, Supernus Pharmaceuticals's market cap has increased from $133.80M to $2.38B, an increase of 1,681.51%. That is a compound annual growth rate of 24.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 2.31B | 15.82% |
| Dec 31, 2024 | 2.00B | 26.29% |
| Dec 29, 2023 | 1.58B | -18.01% |
| Dec 30, 2022 | 1.93B | 24.34% |
| Dec 31, 2021 | 1.55B | 16.99% |
| Dec 31, 2020 | 1.33B | 6.53% |
| Dec 31, 2019 | 1.24B | -28.32% |
| Dec 31, 2018 | 1.74B | -15.02% |
| Dec 29, 2017 | 2.04B | 63.41% |
| Dec 30, 2016 | 1.25B | 90.13% |
| Dec 31, 2015 | 657.50M | 84.54% |
| Dec 31, 2014 | 356.30M | 39.62% |
| Dec 31, 2013 | 255.20M | 45.08% |
| Dec 31, 2012 | 175.90M | 31.46% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.69B |
| Johnson & Johnson | 413.97B |
| AbbVie | 350.24B |
| UnitedHealth Group | 235.02B |
| AstraZeneca | 229.47B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 226.92B |
| Novo Nordisk | 222.88B |